The CEO's $7.5M sale at $100 is the largest insider sale in the trailing 30-day period ($11.9M total). While the company just reported transformative earnings, insider selling at these levels suggests limited near-term upside conviction. Monitor for additional insider sales or any lockup expiration disclosures. The stock's 89% analyst bullish rating may face headwinds if insiders continue to reduce positions.
Price Chart
Executive Summary
CEO Dinesh Patel and Director Bryan Giraudo sold a combined $11.7M in open-market shares within a week of PTGX reporting a massive Q1 2026 earnings beat (revenue $56.4M vs. $16.3M consensus, EPS $0.05 vs. -$0.65 consensus). The sales follow the FDA approval of ICOTYDE and a $200M rusfertide opt-out payment, but the CEO's $7.5M sale at ~$100/share — near all-time highs — raises questions about insider conviction at current valuation. At $11.7M total open-market sales, this represents ~0.17% of PTGX's $6.7B market cap, which is modest but notable given the CEO's participation and the post-earnings timing.
Key Financial Metrics
Key Facts
- CEO Dinesh Patel sold 75,000 shares at $100.12 for $7.51M on May 12, 2026
- Director Bryan Giraudo sold 36,000 shares at $100.14 for $3.61M on May 7, 2026
- Total open-market sales: $11.71M (0.17% of $6.7B market cap)
- Sales occurred 2-7 days after Q1 2026 earnings beat (revenue $56.4M vs. $16.3M consensus)
- CEO also exercised 150,000 options at $0 and $21.58 strike prices (non-cash events)
- Stock is trading near all-time highs following ICOTYDE FDA approval and $200M milestone payment
Financial Impact
Insider sales of $11.71M represent 0.17% of market cap — modest but notable given CEO participation
Risk Factors
- CEO selling near all-time highs may signal peak valuation sentiment
- Further insider sales could pressure stock price
- Post-earnings momentum may fade without additional catalysts
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PTGX-1778628514248 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 10, 2026 7w ago | 144 | $148.29 $145.09 | ▲ +2.16% | ▲ +1.10% | $140.06 (+5.55%) |
Jun 18, 2026 15w ago | 8-K | $115.03 $140.91 | ▲ +22.50% | ▲ +22.65% | $140.06 (+21.76%) |
Jun 12, 2026 16w ago | Institutional Cluster | $109.78 $131.42 | ▲ +19.71% | ▲ +17.93% | $140.06 (+27.58%) |
May 12, 2026 20w ago | 144 | $103.88 $109.79 | ▼ −5.69% | ▼ −6.30% | $140.06 (−34.83%) |
May 8, 2026 21w ago | Insider Cluster | $99.36 $97.38 | ▼ −1.99% | ▼ −2.02% | $140.06 (+40.96%) |
May 8, 2026 21w ago | Insider Cluster | $99.36 $97.38 | ▼ −1.99% | ▼ −2.02% | $140.06 (+40.96%) |
May 5, 2026 21w ago | 8-K | $103.97 $95.41 | ▼ −8.23% | ▼ −11.01% | $140.06 (+34.71%) |
Feb 25, 2026 31w ago | 8-K | $87.10 $104.31 | ▲ +19.76% | ▲ +25.00% | $140.06 (+60.80%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access